Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SNAC has developed and commercialized AI-powered neuroimaging solutions, including iQ-solutions for quantitative brain MRI analysis and VeriScout for automated cerebral haemorrhage detection. These products have received regulatory clearance from the Australian TGA and US FDA, are deployed clinically at major hospitals, and support clinical trials of emerging therapies in neurological diseases such as multiple sclerosis. The company is scaling its SaaS offerings with recent government grant funding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sydney Neuroimaging Analysis Centre.